Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on May 12, 2025
Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance
GlobeNewswire
·
May 12, 2025
BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. …
PyroGenesis Closes $2,385,000 First Tranche in Previously Announced Loan
GlobeNewswire
·
May 12, 2025
MONTREAL, May 12, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes …
Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
GlobeNewswire
·
May 12, 2025
BETHESDA, Md., May 12, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Solo Brands, Inc. Announces First Quarter 2025 Results
GlobeNewswire
·
May 12, 2025
GRAPEVINE, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Solo Brands, Inc. (NYSE: DTC; OTC: DTCB)(1) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel …
Emerging Markets Report: A Milestone for Mycelium
GlobeNewswire
·
May 12, 2025
Underreported D.E.A. Letter and Policy Position Could be a Game Changer for Mushroom Enthusiasts An Emerging Markets Sponsored Commentary ORLANDO, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- At the Emerging Market Report we are comprised of a team of veteran …
Dorel Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
Dorel Juvenile reports strong performance Dorel Home taking further steps to return to profitability MONTRÉAL, May 12, 2025 (GLOBE NEWSWIRE) -- Dorel Industries Inc. (TSX: DII.B, DII.A) today announced its financial results for the first quarter ended …
Dorel annonce ses résultats financiers pour le premier trimestre 2025
GlobeNewswire
·
May 12, 2025
La division Dorel Produits de puériculture fait état d'une solide performance La division Dorel Maison prend de nouvelles mesures pour renouer avec la rentabilité MONTRÉAL, 12 mai 2025 (GLOBE NEWSWIRE) -- Les Industries Dorel inc. (TSX : DII.B, DII.A) a …
Sportradar Reports First Quarter Results
GlobeNewswire
·
May 12, 2025
First Quarter 2025 Highlights Revenue increased 17% to €311 million Profit for the period increased to €24 million and expanded to 7.8% as a percentage of revenue Adjusted EBITDA1 increased 25% to €59 million and Adjusted EBITDA margin1 expanded to 18.9% …
Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress
GlobeNewswire
·
May 12, 2025
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is in three ongoing VESPER Phase 2b trials, with data from VESPER-1 expected in mid-2025 MET-233i, a monthly, ultra-long acting amylin analog, is in Phase 1 trials as a …
Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
GlobeNewswire
·
May 12, 2025
The Company achieved a 29% reduction in absolute scope 1 and 2 greenhouse gas emissions from 2019 levels, surpassing its target of 25% by 2025, ahead of schedule Teva launched two new programs to help people around the world access the medicines they need, …
Classiq Raises $110M in Largest-Ever Quantum Software Funding Round
GlobeNewswire
·
May 12, 2025
TEL AVIV, Israel, May 12, 2025 (GLOBE NEWSWIRE) -- Classiq today announced raising $110 million in Series C funding, the largest ever for a quantum software company. The round was led by Entrée Capital, with participation from Norwest, NightDragon, funds …
TensorStax Raises $5M to Build Deterministic AI Agents for Data Engineers
GlobeNewswire
·
May 12, 2025
SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- TensorStax, the autonomous AI agentic platform for data engineering, today announced it has raised $5 million in Seed funding led by Glasswing Ventures, with participation from Bee Partners and S3 Ventures. …
OTC Markets Group Welcomes Northisle Copper and Gold Inc. to OTCQX
GlobeNewswire
·
May 12, 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Northisle Copper and Gold Inc. (TSX-V: NCX; OTCQX: NTCPF), a Vancouver- …
OTC Markets Group Welcomes OMV AG to OTCQX
GlobeNewswire
·
May 12, 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced OMV AG (Vienna Stock Exchange: OMV; OTCQX: OMVKY, OMVJF), an integrated …
Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire
·
May 12, 2025
Announced positive interim data for LX2006 from Phase 1/2 studies in Friederich ataxia (FA) cardiomyopathy; frataxin expression and LVMI improvement exceeded co-primary target thresholds for planned registrational study LX2006 registrational study expected …
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
GlobeNewswire
·
May 12, 2025
Mike Heffernan appointed as Chairman of the Board Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Cash on hand of approximately $125 million as of March 31, 2025 expected to provide runway …
Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 12, 2025
– Data update from ongoing TNG462 Phase 1/2 monotherapy trial expected 2H 2025 – – Combination trial of TNG462 + Revolution Medicines RAS(ON) inhibitors on track for enrollment 2Q 2025 – – Cash position of $217 million as of March 31, 2025; cash runway …
Harvard Bioscience Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
HOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2025. Jim Green, Chairman and CEO, said, “First quarter revenues were in line …
Wallbridge Announces Notice of Annual and Special Meeting of Shareholders and Spring 2025 Investor Relations Initiatives
GlobeNewswire
·
May 12, 2025
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Wallbridge Mining Company Limited (TSX: WM, OTCQB: WLBMF) (“Wallbridge” or the “Company”) announces that its Annual and Special Meeting (the “Meeting”) will be held via live webcast at: https://virtual-meetings. …
Sionna Therapeutics Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
Phase 1 dosing completed for NBD1 stabilizers SION-719 & SION-451; both compounds continue to be generally well tolerated Phase 1 topline data anticipated this quarter On track to initiate Phase 2a proof-of-concept trial and at least one dual combination …